Search filters

List of works by Kazumoto Iijima

A Case of Congenital Complete Atrioventricular Block Treated with Transdermal Tulobuterol

A Novel Method for Measuring Serum Unbound Bilirubin Levels Using Glucose Oxidase-Peroxidase and Bilirubin-Inducible Fluorescent Protein (UnaG): No Influence of Direct Bilirubin

scientific article published on 16 September 2020

Awareness of and knowledge about mother-to-child infections in Japanese pregnant women

scientific article published on February 2014

Changes in awareness and knowledge concerning mother-to-child infections among Japanese pregnant women between 2012 and 2018

scientific article published on 06 January 2021

Diagnostic Value of Cytomegalovirus IgM Antibodies at Birth in PCR-Confirmed Congenital Cytomegalovirus Infection

scientific article published on 01 July 2019

Diversity of renal phenotypes in patients with WDR19 mutations: Two case reports.

scientific article published in July 2017

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection

scientific article published on 19 March 2019

Efficacy of antiviral treatment on abnormal auditory brainstem responses in congenital cytomegalovirus-infected infants

article

Extremely preterm infants small for gestational age are at risk for motor impairment at 3 years corrected age.

scientific article published on 8 August 2015

Fetal Primary Small Bowel Volvulus Associated with Acute Gastric Dilatation Detected by Ultrasonography

scientific article published on 11 January 2019

Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome

scientific article published on 20 November 2020

Involvement of WNT Signaling in the Regulation of Gestational Age-Dependent Umbilical Cord-Derived Mesenchymal Stem Cell Proliferation.

scientific article published on 12 September 2017

Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection

scientific article published on March 2015

Neurological outcomes at 18 months of age and neonatal risk factors for severe sequelae in congenitally cytomegalovirus-infected infants treated by antiviral treatment early in life

Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment

scientific article published on 14 August 2015

Prediction of Neurodevelopmental Impairment in Congenital Cytomegalovirus Infection by Early Postnatal Magnetic Resonance Imaging

scientific article published on 03 June 2020

Prediction of poor neurological development in patients with symptomatic congenital cytomegalovirus diseases after oral valganciclovir treatment

scientific article published on 07 May 2019

Preliminary Effectiveness and Safety of High Frequency Oscillation in Addition to Mechanical Insufflation and Exsufflation for Intratracheal Mucus Removal in Patients With Neuromuscular Disease: Protocol for a Prospective Study

scientific article published on 27 June 2019

Pulmonary Hypoplasia Caused by Fetal Ascites in Congenital Cytomegalovirus Infection Despite Fetal Therapy

scientific article published on 6 November 2017

Rituximab for nephrotic syndrome in children.

scientific article

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials.

scientific article

Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children

scientific article published on 18 December 2018

Severe retinopathy of prematurity with retinal detachment in monozygotic twins

scientific article published on 01 June 2013

Study protocol: multicenter double-blind, randomized, placebo-controlled trial of rituximab for the treatment of childhood-onset early-stage uncomplicated frequently relapsing or steroid-dependent nephrotic syndrome (JSKDC10 trial)

scientific article published on 02 August 2019

Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-

article